Wall Street Journal Europe

• CAC-40 Index May See Shuffle, 11/20/2001 [text / image]
  PARIS — Four times a year, French stock market officials meet behind closed doors to eject comanies that no longer make the grade in the CAC-40 index and to name the firms that will replace them. This October, people in the know say, they decided to give it a miss. In a way, it's understandable. more...
• Aventis May Make Investors Queasy, 07/21/2001 [text / image]
  PARIS — Investors watching with hope as Aventis holds exclusive talks with Germany's Bayer AG over the sale of its CropScience unit might want to put the group under the microscope one more time. more...
• Prominent Scientists Break Away To Form Swiss Drug Company, 07/11/2002 [text / image]
  PARIS — Several prominent scientists from GlaxoSmithKline PLC and Roche Holding AG are breaking away from their parent companies to form a Swiss firm focusing on compounds for nicotine, alcohol and cocaine dependence. more...
• Alstom Names Former CEO Of Elf as Adviser to Chairman, (with John Carreyrou) 02/22/2002 [text / image]
  PARIS — Moving to allay investors' concerns about its financial disclosure, engineering company Alstom SA named a respected French executive to advise its chairman on financial matters and said it would replace its chief financial officer by the summer. more...
• Weak Dollar Hinders Drug Makers, 07/12/2002 [text / image]
  PARIS — European drug companies that make their best returns in the U.S. will see some of that revenue evaporate as the dollar slips against key European currencies, adding to pressure over earnings uncertainty in the sector. more...
• Has Sanofi Stock Jumped Too High?, 05/29/2001 [text]
  As Sanofi shares reached an all-time high in the afterglow of a shareholders meeting last week, some analysts say sales forecasts are too optimistic and its shares could be vulnerable. more...